Complement component C5 iRNA compositions and methods of use thereof
US-12590305-B2 · Mar 31, 2026 · US
This page is not indexed by search engines while we improve data quality.
Charisse Klaus patents
Charisse Klaus is listed as an inventor on 109 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Charisse Klaus |
| Total patents | 109 |
| First publication | Jun 30, 2015 |
| Latest publication | Mar 31, 2026 |
Notable patents
Publications ranked by popularity score, then publication date.
PCSK9 iRNA compositions and methods of use thereof
US-12460206-B2 · Nov 4, 2025 · US
Extrahepatic delivery
US-12397013-B2 · Aug 26, 2025 · US
MODIFIED RNAi AGENTS
US-2025213720-A1 · Jul 3, 2025 · US
Modified rna agents with reduced off-target effect
US-2025205272-A1 · Jun 26, 2025 · US
Modified rna agents with reduced off-target effect
US-2025207131-A1 · Jun 26, 2025 · US
Modified RNAi agents
US-12290573-B2 · May 6, 2025 · US
Modified RNA agents with reduced off-target effect
US-12275938-B2 · Apr 15, 2025 · US
Modified RNA agents with reduced off-target effect
US-12247203-B2 · Mar 11, 2025 · US
ANGIOTENSINOGEN (AGT) iRNA COMPOSITIONS AND METHODS OF USE THEREOF
US-2025064943-A1 · Feb 27, 2025 · US
Recent patents
Latest publications not already listed above.
SERPINA1 iRNA COMPOSITIONS AND METHODS OF USE THEREOF
US-2025043279-A1 · Feb 6, 2025 · US
Extrahepatic delivery
US-2024358738-A1 · Oct 31, 2024 · US
TMPRSS6 iRNA COMPOSITIONS AND METHODS OF USE THEREOF
US-2024309387-A1 · Sep 19, 2024 · US
SERPINA1 iRNA compositions and methods of use thereof
US-12071619-B2 · Aug 27, 2024 · US
RNAi AGENTS, COMPOSITIONS AND METHODS OF USE THEREOF FOR TREATING TRANSTHYRETIN (TTR) ASSOCIATED DISEASES
US-2024279652-A1 · Aug 22, 2024 · US
COMPLEMENT COMPONENT C5 iRNA COMPOSITIONS AND METHODS OF USE THEREOF
US-2024271136-A1 · Aug 15, 2024 · US
Extrahepatic delivery
US-12005074-B2 · Jun 11, 2024 · US
Compositions and methods for inhibition of expression of apolipoprotein c-iii (apoc3) genes
US-2024110180-A1 · Apr 4, 2024 · US
Complement component C5 iRNA compositions and methods of use thereof
US-11873491-B2 · Jan 16, 2024 · US
Extrahepatic delivery
US-2024009225-A1 · Jan 11, 2024 · US
SERPINC1 iRNA COMPOSITIONS AND METHODS OF USE THEREOF
US-2023365965-A1 · Nov 16, 2023 · US
Modified rna agents with reduced off-target effect
US-2023256001-A1 · Aug 17, 2023 · US
Serpina1 iRNA compositions and methods of use thereof
US-11725207-B2 · Aug 15, 2023 · US
Chirally-enriched double-stranded rna agents
US-2023122244-A1 · Apr 20, 2023 · US
ANGIOTENSINOGEN (AGT) iRNA COMPOSITIONS AND METHODS OF USE THEREOF
US-2023123192-A1 · Apr 20, 2023 · US
Chirally-enriched double-stranded RNA agents
US-11597932-B2 · Mar 7, 2023 · US
Rnai agents, compositions and methods of use thereof for treating transthyretin (ttr) associated diseases
US-2023010288-A1 · Jan 12, 2023 · US
PCSK9 iRNA COMPOSITIONS AND METHODS OF USE THEREOF
US-2023002772-A1 · Jan 5, 2023 · US
Modified RNA agents with reduced off-target effect
US-11504391-B1 · Nov 22, 2022 · US
MODIFIED RNAi AGENTS
US-2022331446-A1 · Oct 20, 2022 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Alnylam Pharmaceuticals Inc | 106 |
| Charisse Klaus | 4 |
| Genzyme Corp | 3 |
| Bettencourt Brian | 3 |
| Milstein Stuart | 3 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| C12N2310/14 | 109 |
| C12N15/113 | 102 |
| C12N2310/315 | 96 |
| C12N2310/321 | 93 |
| A61K31/713 | 85 |